newsfilter
← Latest News
Earnings Call Transcripts·

PACS Group Q3 2026 Earning Call - PACS GROUP INC

  • Financial Performance:

    • Third quarter 2026 revenue reached $1.5 billion, representing an 11.5% year-over-year increase ($154 million).
    • Net income rose 16.2% to $60.8 million; diluted EPS was $0.37.
    • Adjusted net income increased 37% to $104 million; adjusted EPS was $0.63.
    • Adjusted EBITDA grew 33.6% to $175.7 million, including a $4.4 million benefit from California's WQIP program.
    • Same-store skilled nursing revenue increased 6.4% to $1.38 billion; occupancy rose 200 basis points to 91.3% and skilled mix increased 120 basis points to 29.5%.
    • Total portfolio occupancy stood at 90.2% (skilled mix 29.0%); excluding new Aduro acquisitions, occupancy would have been 91.0%.
    • Operating cash flow for the first nine months of 2026 totaled $583.1 million.
    • Capital expenditures and acquisitions for the first nine months were $403.8 million ($376.3 million cash, $27.5 million assumed debt).
    • Ending liquidity was $707.4 million; net leverage ratio was 0.2x.
  • Guidance and Future Outlook:

    • Full-year 2026 revenue guidance raised to $5.95–$6.05 billion; adjusted EBITDA guidance raised to $685–$695 million.
    • Updated guidance reflects 13.1% revenue growth and 37% EBITDA growth over 2025, incorporating $5 million in retroactive Ohio quality payments.
    • Outlook includes consolidation contributions from the 32 Florida facilities (acquired Oct 1) and 11 Texas facilities (acquired Nov 1).
    • Management expects 2027 to continue the trend of strong organic growth and integration of acquired assets, though no formal 2027 guidance is provided.
    • Internal control remediation for material weaknesses is substantially complete, with full effectiveness testing expected by year-end.
  • Business Segments and Product Lines:

    • Portfolio expanded to 355 healthcare facilities across 20 states (38,774 total beds: 35,933 skilled nursing, 2,841 assisted living).
    • Acquired 31 facilities via the Aduro transaction (Texas, Dakotas, New Mexico, Montana) during the quarter.
    • Closed 32 skilled nursing operations in Florida (Oct 1) and 10 skilled nursing plus 1 assisted living operation in Texas (Nov 1).
    • Same-store portfolio consists of 284 facilities; 196 mature, 90 ramping, and 35 new.
    • Mature facilities achieved 93.1% occupancy and 31.3% skilled mix; new facilities started at 76.2% occupancy and 21.1% skilled mix.
    • Administrator in Training (AIT) program now has 54 participants to support leadership pipeline.
    • Real estate strategy includes opportunistic ownership; acquired underlying real estate for six properties in Q3.
  • Market and Competitive Landscape:

    • Florida expansion driven by improved regulatory landscape, higher state-average occupancy/skilled mix, and favorable labor environment.
    • Texas presence deepened with recent acquisition, leveraging existing regional infrastructure.
    • Industry sees a historic influx of deal activity; PACS remains disciplined, targeting moderately performing or distressed assets.
    • Payer focus on quality metrics is intensifying; higher star ratings correlate with better reimbursement rates and access.
    • Labor environment improving with reduced agency usage, aided by federal tuition reimbursement programs for nurses.
  • Risks and Challenges:

    • Ongoing government investigations remain active; management expresses confidence in constructive engagement and resolution from a position of strength.
    • Political shifts (Congressional elections) may introduce regulatory scrutiny (e.g., minimum staffing) or favorable rate adjustments; management views this as normal operating environment.
    • Integration of new acquisitions involves near-term investment costs that temporarily impact margins before yielding organic growth.
    • CMS Quality Measure rating methodology changes and shifting cut points require continuous operational adaptation.
  • Management Commentary and Tone:

    • Tone is highly confident and optimistic regarding organic growth, acquisition integration, and long-term value creation.
    • Emphasis on "operating model" efficacy, particularly in transforming distressed or underperforming facilities into high-quality assets.
    • Highlighted a specific Tennessee facility that graduated from CMS Special Focus status, reaching 85% occupancy through clinical and operational focus.
    • Leadership expressed strong faith in local teams, the AIT program, and the ability to scale into new markets like Florida.
    • Management rejected "growth for growth's sake," stressing disciplined underwriting and capital allocation.
  • Analyst Questions and Answers:

    • Florida Expansion: Justified by improved state dynamics, high baseline occupancy/skilled mix, and talent availability; underwritten to mature cohort standards.
    • Regulatory Environment: Acknowledged potential for stricter staffing rules under Democratic control but noted potential for higher Medicaid/Medicare funding; confident in ability to adapt.
    • Labor Market: Reported reduced agency costs and early elimination of premium labor in new markets; positive trends in attracting direct-hire nurses.
    • 2027 Outlook: Guidance excludes one-time payments (CA/WQIP, OH) but expects continued strong same-store growth and earnings from embedded transaction value.
    • M&A Pipeline: Seeing record deal flow; pipeline includes larger portfolio transactions and tuck-ins in established states.
    • Real Estate: Capital allocation is opportunistic; ownership purchases do not detract from acquisition capability due to strong cash flow.
    • Mature Facility Performance: Expect continued growth in mature cohorts (currently 93% occupancy) as they move toward 100% occupancy/skilled mix targets.
  • Other Key Points:

    • 78.9% of skilled nursing facilities (250 total) hold 4 or 5-star CMS ratings; mature facilities average 4.5 stars.
    • GAAP rent expense exceeded cash rent payments by $10.1 million in Q3 due to accounting standards.
    • G&A expense increased due to $45.3 million in stock-based compensation (including accelerated vesting); underlying G&A grew only 3.4%.
    • DSOs decreased by 2–3 days, contributing to strong cash conversion.
    • Full $250 million share repurchase authorization remains available.
Company
PACS GROUP INC
Keywords
PACS GROUP INC